17/08/2022
“In January, the US Drug Enforcement Agency announced plans to ban 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT, five little-known psychedelic compounds of the tryptamine variety. By designating them as Schedule 1, these obscure drugs would not only have been made illegal to possess and sell, but research would’ve also been made much more difficult.
Instead, the DEA has announced they are backtracked on the idea of adding these five psychedelics to Schedule 1 —at least for now.”
This week the DEA announced it would withdraw its plan to schedule 5 research psychedelics. But we shouldn't celebrate just yet